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Objective: To investigate, as a discovery phase, if 3D knee kinematics assessment parameters can serve as
mechanical biomarkers, more speciﬁcally as diagnostic biomarker and burden of disease biomarkers, asKeywords:
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deﬁned in the Burden of Disease, Investigative, Prognostic, Efﬁcacy of Intervention and Diagnostic
classiﬁcation scheme for osteoarthritis (OA) (Altman et al., 1986). These biomarkers consist of a set of
biomechanical parameters discerned from 3D knee kinematic patterns, namely, ﬂexion/extension,
abduction/adduction, and tibial internal/external rotation measurements, during gait recording.
Methods: 100 medial compartment knee OA patients and 40 asymptomatic control subjects participated
in this study. OA patients were categorized according to disease severity, by the Kellgren and Lawrence
grading system. The proposed biomarkers were identiﬁed by incremental parameter selection in a
regression tree of cross-sectional data. Biomarker effectiveness was evaluated by receiver operating
characteristic curve analysis, namely, the area under the curve (AUC), sensitivity and speciﬁcity.
Results: Diagnostic biomarkers were deﬁned by a set of 3 abduction/adduction kinematics parameters.
The performance of these biomarkers reached 85% for the AUC, 80% for sensitivity and 90% for speciﬁcity;
the likelihood ratio was 8%. Burden of disease biomarkers were deﬁned by a 3-decision tree, with sets of
kinematics parameters selected from all 3 movement planes.
Conclusion: The results demonstrate, as part of a discovery phase, that sets of 3D knee kinematic
parameters have the potential to serve as diagnostic and burden of disease biomarkers of medial com-
partment knee OA.
& 2017 Elsevier Ltd. All rights reserved.1. Introduction
In 2001, the National Institutes of Health (NIH) deﬁned bio-
markers as objectively-measured and evaluated characteristics or
indicators of normal/pathogenic biological processes, including
pharmacological responses to therapeutic or other healthcare
interventions (Felson and Lohmander, 2009). Biomarkers have
attracted scientiﬁc interest in the medical ﬁeld because they can
be useful along the whole spectrum of disease progression.e la TÉLUQ, 5800 Rue Saint-
zghani),
i.ca (A. Fuentes),
@etsmtl.ca (N. Hagemeister),There are 2 main groups of biomarkers for the diagnosis of
knee osteoarthritis (OA) (Bauer et al., 2006): biochemical (wet
biomarkers) and structural (dry biomarkers). Biochemical markers
are commonly extracted from blood, urine and synovial ﬂuids.
They can reﬂect articular tissue turnover or pathological progres-
sion. Recent studies have reported their limited diagnostic test
performances (Hunter et al., 2007; Felson and Lohmander, 2009),
which could explain why they are not routine clinical measures.
Structural biomarkers are typically extracted from imaging
modalities, such as X-ray, computed tomography and magnetic
resonance imaging (MRI). Biomarkers taken from X-ray images,
such as joint space width, joint space area and bone trabecular
integrity, can aid in assessing disease burden. Even if radiography
remains the gold standard in conﬁrming OA diagnosis in clinical
settings, its extraction of biomarkers harbors limitations of tech-
nique and sensitivity (Hunter et al., 2007).
Table 1
General subject characteristics considered for diagnostic biomarkers.
OA patients (n¼40) Non-OA patients (n¼40)
Mean SD Mean SD
Age (year) 62.40 8.27 48.6 18.47
Height(m) 1.61n 0.09 1.67 0.10
Weight (kg) 82.28 18.84 69.70 11.87
BMI (kg/m2) 31.20 5.59 24.69 3.05
Walking speed (m/s) 1.31 0.96 2.47 1.42
Proportion of women/
men
24/16 16/24
n Signiﬁcant difference between groups with a Po0.05.
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are sensitive to changes and therefore appropriate in evaluating
new disease-modifying OA drugs (Eckstein and Le Graverand
2015). MRI of cartilage and bone morphometry allows the
assessment of parameters, such as cartilage volume and thickness,
subchondral bone plate area and mean bone curvature (Hunter, et
al., 2008; Hunter et al., 2011; Hayashi et al., 2014). While MRI is
generally not clinically necessary to help clinicians diagnose OA or
deﬁne patient care pathways, associated costs limit its use outside
clinical trials. Clinical testing – which could be expedient in both
patient management (to assist clinicians in developing treatment
plans) – with biomarker extraction would be beneﬁcial.
The NIH-funded Osteoarthritis Biomarkers Network – a multi-
disciplinary group interested in the development and validation of
OA biomarkers – proposed the BIPED (Burden of Disease, Investiga-
tive, Prognostic, Efﬁcacy of Intervention and Diagnostic) biomarker
classiﬁcation scheme in 2006 to characterize and classify OA bio-
markers (Bauer et al., 2006). The scheme offers suggestions on
optimal study design and analytical methods in OA biomarker
investigation. Such biomarkers are needed by researchers and clin-
icians for OA diagnosis, disease severity grading, and management of
disease progression (Altman et al., 1986; Mezghani et al., 2012).
The purpose of this study was to establish, as a discovery phase, if
3D knee evaluation parameters in clinical settings could serve as
“mechanical” biomarkers. Based on a previous publication (Jones et
al., 2006), demonstrating the sensitivity of biomechanical data to
objectively discriminate knee OA patients from healthy controls and
additionally distinguish OA patients based on radiographic disease
severity (Mezghani et al., 2012), the objective was to evaluate dif-
ferent combinations of biomechanical parameters that would best
function as diagnostic and burden of disease biomarkers, as deﬁned
in the BIPED classiﬁcation scheme for OA (Bauer et al., 2006). These
biomarkers would consist of sets of biomechanical parameters gar-
nered from 3D knee kinematic measurements, namely, ﬂexion/
extension (Flex/Ext), abduction/adduction (Abd/Add) and tibial
internal/external (Int/Ext) rotation recorded during walking. Con-
sidering biomechanical data as biomarkers has interesting clinical
advantages: (i) they are objective measures, (ii) they reﬂect func-
tional joint status in dynamic and weight-bearing conditions, and
(iii) they could guide treatment plans (Gaudreault et al., 2011;
Fuentes et al., 2013; Hunter et al., 2013).2. Materials and methods
2.1. Study participants
This study was approved by institutional ethics committees, with all subjects
providing written informed consent before it began. Two groups participated in the
study. The ﬁrst group included 100 patients with predominantly medial compartment
knee OA diagnosed according to clinical and radiographic criteria deﬁned by Altman
et al. (Altman et al., 1986). Participants were classiﬁed in terms of radiographic OA
disease severity according to the Kellgren and Lawrence (KL) scaling system (grades
0–4) (Kellgren and Lawrence, 1957). They were categorized as follows: 25 grade 1
(KL1), 25 grade 2 (KL2), 25 grade 3 (KL3), and 25 grade 4 (KL4). The patients were
excluded if they had vestibular, neurological, or musculoskeletal disorders, fracture of
the lower extremity, rheumatoid arthritis, or generalized osteoarthritis, limping gait or
any condition that could affect a treadmill walking evaluation.
In the second group, 40 asymptomatic participants (non-OA) formed a control
group. All asymptomatic participants were evaluated by a physician and were
excluded if they had any orthopedic (joint fracture, joint laxity, OA or arthritis) or
neurological problems that could affect their gait pattern. For ethical reasons, these
participants did not have an X-ray. That is the reason why they are called asymp-
tomatic and not “normal” or “healthy” subjects. Tables 1 and 2 summarize parti-
cipants’ demographic characteristics and their walking speed.
2.2. Biomechanical parameter extraction
Three-dimensional (3D) knee kinematics data (Flex/Ext, Abd/Add and Int/Ext
rotation), from the sagittal, frontal and transverse planes respectively, were recordedwhile each participant walked on a treadmill at a self-selected, comfortable speed.
KneeKGTM, a knee marker attachment system designed to reduce skin-motion arti-
facts (Lustig et al., 2012), was installed on participants’ knees to record 3D kinematics
during gait trials. Accuracy of the attachment system was assessed in studies which
evaluated the mean repeatability of measures ranging from 0.4° to 0.8° for knee
rotation angles and from 0.8 to 2.2 mm for translation (Sati et al., 1997; Hagemeister
et al., 2005). Intra- and inter-observer reliability of the attachment system for
recording 3D knee kinematics during gait was also ascertained (Labbe et al., 2008).
The kinematics data were represented over several gait cycles (GCs). The curves
that maximize the intra subject correlation index are averaged to obtain mean GCs
per participant. This was followed by resampling from 1% to 100% of GCs with 100
measurement points for each participant in each plane (Fig. 1). A set of 70 bio-
mechanical parameters of interest was then extracted from these 3D kinematic
patterns for data analysis. The objective was to evaluate different combinations of
biomechanical parameters that would best function as diagnostic and burden of
disease biomarkers. The parameters chosen to be extracted were based on variables
routinely assessed in clinical biomechanical studies of knee OA populations, such as
maximums, minimums, varus and valgus thrust, angles at initial contact, mean
values and range of motion (ROM) throughout GCs or GC sub-phases (i.e., loading,
stance, swing, etc.) (Astephen et al., 2008; Bytyqi et al., 2014).
2.3. Mechanical biomarkers
We assessed whether sets of 3D knee kinematic parameters could act as bio-
markers and, more speciﬁcally, as diagnostic and burden of disease biomarkers,
both meeting speciﬁcations of the BIPED classiﬁcation scheme for OA ((Bauer et al.,
2006), Table 1, pp. 726).
Diagnostic biomarkers are evaluated for their ability to classify individuals as
either diseased or non-diseased (Bauer et al., 2006). The purpose of the proposed
mechanical biomarkers is therefore to be able to distinguish OA-diseased knees
from non-diseased knees (non-OA in this study). The literature suggests that bio-
markers evaluation needs to be compared to an independent gold standard (Felson
and Lohmander, 2009). For knee OA, an accepted gold standard of OA diagnosis OA
is combination of physical assessment and conﬁrmation by radiographic imaging
(Hunter and Pollo, 2015). Therefore, in the present study, OA was conﬁrmed by
clinical physical assessment by orthopedic surgeon or sports medicine physician
with a radiographic evaluation. Radiography from different imaging centers was
evaluated as weight-bearing anterior-posterior X-rays. The presence of OA changes
on X-rays was conﬁrmed by radiologist, orthopedic surgeon or sports medicine
physician. The database was collected from three different centers. This multicenter
database affords a better representation of the population diversity and clinical
reality. Based on different cohorts of OA patients, previous studies determined that
the reliability of inter-rater trained readers of KL grading was 0.63–0.83 (Scott et al.,
1993). We did not assess the inter-rater reliability of our X-Ray evaluators. How-
ever, they were all very familiar with knee OA and we expect their inter-rater
reliability to be at least as good as that reported in the literature.
To be considered as valid disease biomarker, the identiﬁed set of biomechanical
parameters would need to classify patients based on their radiographic disease
severity. The classiﬁcation result should be in concordance with the KL grading
scale assessed by 1 of 3 experienced evaluators (orthopedic surgeon, radiologist or
sports medicine physician). Based on different cohort OA patient, previous studies
reported good inter-rater reliability of KL grading (Hunter and Pollo, 2015). Burden
of disease biomarkers were evaluated according to rates of correct grade prediction,
i.e., KL1, KL2, KL3 or KL4.
2.4. Statistical analysis
Kinematic parameters that would act as biomarkers were identiﬁed by incre-
mental selection on a regression tree determining the best set of biomechanical
parameters for each biomarker type: knee OA disease diagnosis and severity
grading. Regression trees are widely used in literature for prediction application
Table 2
General OA patients’ characteristics considered for burden of disease biomarkers (n¼100).
KL1 (n¼25) KL2 (n¼25) KL3 (n¼25) KL4 (n¼25)
Mean SD Mean SD Mean SD Mean SD
Age (year) 56.33 10.67 58.63 7.72 62.84 10.13 61.28 5.69
Height(m) 1.66 0.11 1.65 0.09 1.63 0.12 1.62 0.1
Weight (kg) 80.06 14.56 82.72 16.91 79.60 16.28 90.36 19.64
BMI (kg/m2) 28.72(4) 3.20 30.18(4) 5.91 29.35(4) 3.98 34.00(1.2.3) 5.04
Walking speed (m/s) 2.50 1.44 2.72(4) 1.15 2.76(4) 1.33 1.58(2.3) 0.92
Proportion of women/men 18/7 17/8 19/6 21/4
Signiﬁcance during post hoc t-tests is denoted by letters representing which group was compared (1: KL1; 2: KL2; 3: KL3; 4: KL4). Signiﬁcance was set at po0.05.
Fig. 1. Kinematic patterns in the three planes: ﬂexion/extension (sagittal plane), abduction/adduction (frontal plane), and tibial internal/external rotation (transverse plane)
for one typical subject.
Fig. 2. Regression tree used to determine the diagnostic biomarker, i.e., to differ-
entiate between knee OA and non-OA patients. The identiﬁed biomarkers are the
mean Abd/Add angle during stance phase, the Abd/Add angle at initial contact, and
the minimum of Abd/Add angle during loading phase.
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interpretation are straightforward (Henrard et al., 2015). Analysis was undertaken
with Matlab R2014b software (Mathworks, Massachusetts, United State).
We generated a total of 4 tree-based models to select the optimal combination
of biomechanical parameters. Only 1 selection tree was built to identify diagnostic
biomarkers, i.e., to differentiate knee OA from non-OA patients. For this purpose,
we tested the kinematic parameters of 40 OA patients and 40 non-OA subjects. The
40 OA patients were chosen randomly from our database of 100 OA patients, to
study the same number of non-OA subjects. Table 1 summarizes the demographic
characteristics of participants and their walking speed. These characteristics were
compared by Student's t-test which is a common statistical test to determine
whether two samples have the same mean. The Student t-test assumes that the
data in the samples are normally distributed (Sugimoto et al., 1977). We veriﬁed the
normality of our data. The threshold of Student t-test signiﬁcance was set at 0.05.
Totally, 3 selection trees were needed to deﬁne burden of disease biomarkers. For
this purpose, the entire dataset of 100 OA knees was composed of 25 KL1, 25 KL2, 25
KL3, and 25 KL4 grades. In a discovery phase at least 10 subjects per subgroup are
needed to identify biomarkers (Jimenez and Verheul, 2014). Among the database, 25
subjects with identical KL were the smallest subgroup. The other three groups have
been selected randomly in the database to have 4 equivalent groups.
Table 2 summarizes the demographic characteristics of participants and their
walking speed. Group homogeneity was veriﬁed by analysis of variance. The ﬁrst step
consisted of a selection tree classifying OA patients into 2 main groups: moderate OA
grades (regrouping KL1 and KL2 together (KL1-2)) and severe OA grades (regrouping
KL3 and KL4 grades together (KL3-4)). Note that intermediate selection is necessary to
grade disease severity because of dissimilarity between KL1 and KL2 biomarker and
KL3 and KL4 biomarker (as explained in Section 3.2). Finally, the last 2 selection trees
were developed to subdivide moderate OA (KL1-2) and severe OA groups (KL3-4) to
obtain 4 separate grades (KL1 to KL4). Differences between pairs of the 4 KL severity
groups were examined by post hoc Turkey test. Statistics were processed with SPSS
18.0 (Statistical Package for Social Sciences) (SPSS Inc. Released, 2009. PASW Statistics
for Windows). The threshold of signiﬁcance was set at 0.05.
The effectiveness of biomechanical parameters identiﬁed by regression tree as
biomarkers was evaluated by receiver operating characteristic (ROC) curves: area
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Sarin, 2009). To be an effective clinical tool, the biomarker should have high AUC,
sensitivity, speciﬁcity and low likelihood ratio values. In the present study, the AUC
is used as a major indicator for estimating the performance of the biomarkers.
Biomarker measurements were computed by a cross-validation method, which
consisted of splitting the dataset into 2 parts, one for model building and the other
for model evaluation. In our study, we reserved 10% of the dataset for evaluation,
which led to 10-fold cross-validation procedure: the data set is divided into 10
subsets. Each time, one of the 10 subsets is used as the test set and the other
9 subsets are used as the training set. The classiﬁcation performance is computed at
each time and the average error across all 10 trials is estimated. This division was
necessary for objective evaluation (Horvatovich and Bischoff, 2013).
When kinematic parameter sets were deﬁned, they were tested, in their
respective trees, to predict knee OA and grade its severity, as illustrated in Figs. 2–5.3. Results
3.1. Diagnostic biomarker
Among 70 biomechanical parameters extracted, a set of 3 Adb/Add
parameters was identiﬁed as diagnostic biomarker to differentiateFig. 3. The intermediate selection tree classifying OA patients into 2 main groups: mod
(regrouping KL3 and KL4 grades together (KL3-4)).knee OA from non-OA patients: Abd/Add angle at initial contact,
minimum Abd/Add angle during the loading phase, and mean Abd/
Add angle during the stance phase (see Fig. 2 for threshold values).
The performance of this biomarker was 85% for the AUC, 80% for
sensitivity, 90% for speciﬁcity, and the likelihood ratio was 8%.
3.2. The burden of disease biomarker
Three selection trees identiﬁed burden of disease biomarkers.
The ﬁrst, consisting of an intermediate tree, separated moderate
grade OA (KL1 and KL2 grades) from severe grade OA (KL3 and
KL4). A set of 4 parameters was extracted for discrimination
(Table 3, row 1): ﬂexion angle at the end of the stance phase,
ﬂexion angle maximum, ROM of Int/Ext rotation during swing
phase and ROM of the Abd/Add during loading phase (Fig. 3). The
Performance of the intermediate selection tree, which classiﬁed
OA severity in 1 of 2 categories (KL1-2 and KL3-4), was 86% for
the AUC.
To discriminate KL1 from KL2 grades, the second selection tree
identiﬁed and used 4 kinematic parameters (Table 3, row 3): Int/erate OA grades (regrouping KL1 and KL2 together (KL1-2)) and severe OA grades
Fig. 4. Regression tree to differentiate KL1 from KL2 grades. The biomarker is the Int/
Ext rotation angle at the initial contact, the ﬂexion angle at the end of the stance phase,
the max of the Abd/Add angle during swing phase, and the ROM of the Int/Ext rotation.
Fig. 5. Regression tree to differentiate KL3 from KL4 grades. The biomarker is the
Int/Ext rotation absolute angle value at initial contact, the Abd/Add angle at the end
of the loading phase and its ROM.
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stance phase, maximum of the Abd/Add angle during swing phase
and ROM of the Int/Ext rotation (Fig. 4). The performance of this
biomarker (set of 4 kinematic parameters) was 88.2% for the AUC,
91.6% for sensitivity and 85.1% for speciﬁcity.
The last set consisted of 3 kinematic parameters acting as
biomarker to discriminate KL3 from KL4 subjects (Table 3, row 4):
Int/Ext rotation absolute angle value at initial contact, Abd/Add
angle at the end of the loading phase and ROM (Fig. 5). Biomarker
performance was 88% for the AUC, 84% for sensitivity and 92% for
speciﬁcity.4. Discussion
The purpose of this study is to investigate if 3D knee kinematics
assessment parameters can serve as mechanical biomarkers. The
proposed biomarkers were identiﬁed by incremental parameter
selection in a regression tree of cross-sectional data. Our study
differs from other studies in several important ways: (1) The
biomarkers identiﬁcation is based on machine learning, which can
select speciﬁc mechanical biomarkers from a large set of bio-
mechanical parameters (as shown in Table 4), (2) the decision tree
can be visualized and has a structure simple enough to be used
and interpreted by clinicians, (3) the study is performed on a lar-
ger number of OA patients, which gives a stronger data support for
interpretation and, (4) being vectors of biomechanical parameters,
the biomarkers are richer descriptions than single parameter
representations for better description of OA grading (Jones et al.,
2006; Mezghani et al., 2008, Mezghani et al., 2016).
Traditionally, kinetic variables have been more thoroughly
established (particularly the external knee adduction moment) as
factors in the progression and severity of knee OA, their collection
still needs sophisticated setups which are, generally, available only
in gait labs (Simon, 2004). Our method only needs a commercial
treadmill and the use of the attachment system to acquire non-
invasive kinematic measurements in normal clinical setting. This
enhances originality and clinical applicability of the method.
Criteria derived from ROC curve analysis of diagnostic bio-
markers, i.e., AUC (85%), sensitivity (80%), speciﬁcity (90%), demon-
strate that Abd/Add angle at initial contact, minimum Abd/Add angle
during the loading phase, and mean Abd/Add angle during the
stance phase, well discriminate OA from non-OA subjects. These
values strongly support the association between biomarkers and
knee OA diagnosis. They also support previous publications showing
that biomechanical data during gait assessment can discriminate
knee OA patients from non-OA participants and, therefore, poten-
tially become diagnostic aids (Jones et al., 2006; Mezghani et al.,
2012).
The results also disclose that, of the 3 movement planes, Abd/
Add angle, known clinically as valgus/varus representation, is the
most useful parameter, serving as a diagnostic biomarker. This is
consistent with a previous study that demonstrated strong cor-
relations between frontal plane kinematic parameters and a knee
radiographic grading system (Blouin et al., 2014). Furthermore,
earlier work (Yang et al., 2010; Hunter and Pollo, 2015) has
determined that, in knee OA patients, frontal plane alignment and
stance-phase adduction moment are determinants in medial
compartment loading which may play a role in knee OA symp-
toms. Other biomechanical investigations have indicated that knee
Abd/Add alignment can be ﬂagged as an efﬁcacious intervention
marker (Teichtahl et al., 2009). These markers are of great interest
because they are based on objective and functional measures.
Bauer et al. deﬁned burden of disease markers as assessments
of disease severity at some time points (Bauer et al., 2006). In the
present study, burden of disease biomarkers were deﬁned by a set
of relevant biomechanical parameters selected from 3 plane
kinematic curve measurements. Indeed, high AUCs (88.2% and
82%, respectively), for KL1 differentiation from KL2 and KL3 dif-
ferentiation from KL4, demonstrated strong associations between
grading biomarkers and knee OA severity. Note that even when
tested on moderately diseased knees (KL1 and KL2), the AUC
reaches 88.2%, meaning that the biomarker separates these
grades well.
The AUC of the intermediate selection tree showed that ﬂexion
angle at the end of the stance phase, ﬂexion angle maximum, ROM
of Int/Ext rotation during swing phase and ROM of the Abd/Add
during loading phase well discriminate between moderate OA
grades (regrouping KL1 and KL2 grades together) and severe OA
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compared a set of biomechanical parameters in patients categor-
ized as moderate to severe OA grades (Thorp et al., 2006). It was
reported that both peak knee adduction moment and knee
adduction angular impulse increased with KL radiographic grade
(po0.05). Other studies have also shown that kinematic para-
meters correlate well with OA severity (Astephen et al., 2008;
Astephen Wilson et al., 2011; Mezghani et al., 2012), Therefore,
within biomechanical parameters, kinematics and kinetics vari-
ables can be considered as burden of disease markers.
Statistical analysis usually revealed no signiﬁcant statistical
differences in general characteristics between OA and non-OA
participants (Table 1) and within the 4 KL groups (Table 2).
The biomarkers and their respective trees were further inves-
tigated to predict knee OA and grade its severity, as shown in
Figs. 2–5. Although these trees may seem complex, data acquisi-
tion as well as the evaluation and use of biomarkers for diagnosis
and disease severity grading are entirely automatic, so that its
complexity has little impact in practice.
The statistical analysis reveals differences of BMI and walking
speed that include only the KL4 group compared to other KL
groups, so that there was no speciﬁc additional analysis we needed
to do on the possible effect of BMI and walking speed on the
biomarkers performance. Although the percentage of female to
male in each KL group was not comparable, the Chi square test
reveals no signiﬁcant statistical difference between these propor-
tions within the four KL groups (Table 2).
The proposed biomarkers present interesting characteristics:
(i) they are kinematic measures that reﬂect functional status of the
knees, (ii) unlike static X-ray image assessment, these parametersTable 3
Sets of parameters retained as diagnostic and burden of disease biomarkers.
Classes Set of parameters retained as biomarkers
OA/non-OA (Burden of
disease)
 Mean Abd/Add angle during stance phase
 Abd/Add angle at initial contact
 Minimum of the Abd/Add angle during
loading phase
KL1-2/KL3-4  Flexion angle at the end of the stance phase
 ROM of Int/Ext rotation during swing phase
 Flexion angle maximum
 ROM of the Abd/Add during loading phase
KL1/KL2  Int/Ext rotation angle at initial contact
 Flexion angle at the end of the stance phase
 Max of the Abd/Add angle during swing phase
 ROM of the Int/Ext rotation.
KL3/KL4  Int/Ext rotation absolute angle value at initial
contact
 Abd/Add. angle at the end of the loading phase
 ROM of the Abd/Add angle
Table 4
Mechanical biomarkers.
KL1 (n¼24)
Mean SD
Flexion angle at the end of the stance phase 8.46 4.78
ROM of Int/Ext rotation during swing phase 0.44 1.64
Flexion angle maximum 57.41 8.17
ROM of the Abd/Add during loading phase 1.83(3) 1.43
Int/Ext rotation absolute angle value at initial contact 3.75 2.37
Max of the Abd/Add angle during swing phase 3.36(3,4) 3.95
ROM of the Int/Ext rotation 10.29 2.55
Int/Ext rotation angle at initial contact 3.75(4) 2.37
Abd/Add. angle at the end of the loading phase 1.73(3,4) 3.59
ROM of the Abd/Add angle 8.29(2) 2.65
Signiﬁcance during post hoc t-tests is denoted by letters representing which group wasare objective measures with a non-invasive and non-radiant
modality, and (iii) variables collected during functional assess-
ment can also be adopted by healthcare professionals to perso-
nalize care pathways for knee OA patients.
In a recent study, the authors address the identiﬁcation of gait
characteristics for the various disease stages of hip OA using a
principal component analysis that allows the statistical evaluation
of whole biomechanical signals (Ardestani and Wimmer, 2016). In
our case, we used a set of biomechanical parameters based on
variables routinely assessed in clinical biomechanical studies of
knee OA. This set of parameters is as rich a description as possible
for a meaningful representation of the 3D knee kinematics. Other
studies shown that 3D knee kinematics assessment parameters
present great potential for investigative, prognostic, and efﬁcacy of
intervention in knee OA (Gaudreault et al., 2011; Fuentes et al.,
2013, Hunter et al., 2013). In the future, we will investigate if they
can serve as mechanical biomarkers as described in BIPED classi-
ﬁcation scheme.
Our study has some limitations. The results might only be
applicable to patients with predominant medial compartment
knee OA. Since biomechanical measures can be inﬂuenced by knee
kinematics acquisition methodologies, the results might be
acquisition-dependent. The statistical analysis was based on a
multicenter database to better represent the clinical reality.
However, this implies a methodological limitation. For example,
3 different experienced evaluators have assessed the KL grades.
Finally, the fact that our control group did not undergo an x-ray
evaluation is a limitation for the diagnostic biomarkers since we
have no guaranty that these asymptomatic participants had no
radiological signs of OA. Previous study showed similar knee
loading patterns during gait in asymptomatic participants with KL
0 or 1 and asymptomatic participants with KL 2 grade (Thorp et al.,
2006), and therefore we cannot rule out the possibility of having
subjects with radiological sign of OA in our asymptomatic group.5. Conclusion
The diagnostic and burden of disease biomarkers proposed in
this study can objectively assist in knee OA diagnosis and disease
severity grading. Diagnostic biomarkers are deﬁned by a set of
relevant kinematics parameters selected from Abd/Add movement
planes. The 3 burden of disease biomarkers implicated are deﬁned
by sets of relevant biomechanical parameters selected from
3 movement planes. These biomarkers can be embraced as diag-
nostic tools, even in the early OA stage, and help in the develop-
ment of treatment plans. The proposed biomarkers could help in
ﬁrst-line OA diagnosis efﬁciently, objectively and non-invasively.KL2 (n¼27) KL3 (n¼25) KL4 (n¼25)
Mean SD Mean SD Mean SD
7.509(4) 4.62 8.80 6.04 14.93(2) 25.34
1.48 2.02 0.20 3.03 1.61 5.49
60.17 7.01 57.13 7.33 59.42 20.29
1.85(3) 1.20 2.65(1,2) 1.29 2.10 1.59
3.62 2.82 4.76(4) 3.20 2.70(3) 2.61
4.36(3,4) 5.19 7.14(1,2) 3.73 8.53(1,2) 4.20
11.29 4.03 10.05 4.03 15.44 36.23
3.05 3.45 3.39(4) 4.68 1.33 3.55
1.76(3,4) 3.78 5.08(1,2,4) 3.90 7.51(1,2,3) 4.31
10.84(1,3,4) 3.63 8.68(2,4) 2.54 6.71(2,3) 2.82
compared (1: KL1; 2: KL2; 3: KL3; 4: KL4). Signiﬁcance was set at po0.05.
N. Mezghani et al. / Journal of Biomechanics 52 (2017) 106–112112Future studies need to test the reliability of these biomarkers on
other larger databases of different research groups.Role of the funding source
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